QZS
1 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- Software-Aided Adjunctive Diagnostic Device For Use By Physicians On Lesions Suspicious For Skin Cancer
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 878.1830
- Medical specialty
- General, Plastic Surgery
- FDA definition
- A software-aided adjunctive diagnostic device for use by physicians on lesions suspicious for skin cancer is a prescription device that uses a software algorithm to analyze optical or other physical properties of a skin lesion and returns a classification of the skin lesion. The device is intended for use by a physician not trained in the clinical diagnosis and management of skin cancer as an adjunctive second-read device following identification of a suspicious skin lesion. It is not for use as a standalone diagnostic and is not for use to confirm a clinical diagnosis.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| DermaSensor (DEN230008) | Dermasensor, Inc. | 2024-01-12 |
Track QZS automatically
Every clearance here is in the API, with alerts when new ones post.